Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
NCT07334834 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-01-23
Summary
This is a randomized, controlled, collaborative, multicenter, pilot implementation science study evaluating the hypothesis that algorithm- and multi-professional team-supported lipid management reduces low density lipoprotein-cholesterol (LDL-C) compared with usual care in patients with atherosclerotic cardiovascular disease (ASCVD).
Conditions
Interventions
- OTHER
-
Algorithm- and multi-professional team-supported lipid management
Algorithm- and multi-professional team-supported lipid management
- OTHER
-
Guideline-directed lipid management by usual care provider
Guideline-directed lipid management by usual care provider
Sponsors & Collaborators
-
Colorado Prevention Center
lead OTHER
Principal Investigators
-
Marc Bonaca, MD · Colorado Prevention Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-10
- Primary Completion
- 2027-05-31
- Completion
- 2027-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
NCT00327691 ·Status: COMPLETED ·Phase: PHASE4
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536965 ·Status: COMPLETED
-
A Study in People With High Cholesterol
NCT00133380 ·Status: COMPLETED ·Phase: PHASE2
-
Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand
NCT00684151 ·Status: COMPLETED
-
Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery
NCT07064135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol
NCT00283335 ·Status: COMPLETED ·Phase: PHASE3
-
Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
NCT00143234 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
NCT00616772 ·Status: COMPLETED ·Phase: PHASE3
-
Tracking of Lipid Lowering Therapy in Jordan
NCT05629767 ·Status: TERMINATED
-
Lipid Management in Clinical Practice (MK-0524A-115)
NCT01071278 ·Status: COMPLETED
-
Study of A3309 in Patients With Dyslipidemia
NCT01069783 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease
NCT03355027 ·Status: UNKNOWN ·Phase: NA
-
National Survey on Dyslipidemic Patients
NCT00701402 ·Status: COMPLETED
-
Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol
NCT01959971 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
NCT00203476 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of LY3015014 in Participants With High Cholesterol
NCT01890967 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
NCT02714569 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
NCT01078285 ·Status: COMPLETED
-
Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia
NCT00557778 ·Status: COMPLETED
-
Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
NCT00300456 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides
NCT00812955 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
NCT03696940 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI
NCT03718286 ·Status: COMPLETED ·Phase: PHASE2
-
Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)
NCT00736463 ·Status: UNKNOWN ·Phase: PHASE4
-
Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)
NCT00653835 ·Status: COMPLETED ·Phase: PHASE4